Vinorelbine is a small molecule and antimitotic chemotherapy agent approved by the FDA in 1994 for non–small cell lung cancer, and T-DM1 is an antibody–drug conjugate and anti-HER2 therapy approved in 2013 for metastatic breast cancer. The gene discussed is ERBB2; the disease is lung cancer.